Delivery Order SPE2DB22D2005-SPE2DB25FJHM6

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,086.40, is a Firm Fixed Price Delivery Order for the supply of BRIVIACT 100 MG TABLET 60S, a medication. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,987.29 and covers the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and an ultimate completion date of July 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.21 Firm Fixed Price Delivery Order contract is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,815.74 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a specialty medication. The contract has an ultimate completion date of November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,654.78. It is a firm fixed-price delivery order contract with a completion date of November 6, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,790.87 firm-fixed-price delivery order is for the supply of BRIVIACT 50 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,007.39, is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 3, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,151.50, is for the medical product "BRIVIACT 10 MG/ML ORAL SOLN 300ML". The contract has an ultimate completion date of July 15, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with any set-aside requirements,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,792.01, is for the delivery of BRIVIACT 25 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and is structured as a firm-fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,148.32, is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJHM6
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,649.57, is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 18, 2025.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed has no set-aside designation, indicating open competition.

Generated 5/16/25, 12:08 PM